| 1 | Organizational and pharmaceutical aspects of improving medic… (10.31549/2542-1174-2020-1-31-43) | Abstract References ORCID License | 114.61 | 13 |
| 2 | Risk factors for unfavorable outcome of the disease in patie… (10.31549/2542-1174-2019-3-33-43) | Abstract References ORCID License | 69.90 | 4 |
| 3 | Etiological and pathomorphological characteristics of congen… (10.31549/2542-1174-2020-3-52-63) | Abstract References ORCID License | 69.90 | 4 |
| 4 | The spectrophotometric determination of A-vitamin activity o… (10.31549/2542-1174-2021-4-17-26) | References ORCID License | 67.73 | 7 |
| 5 | Marketing research on the national antiepileptic drug market… (10.31549/2542-1174-2022-6-4-48-60) | References ORCID License | 63.38 | 6 |
| 6 | Structure of dermatological pathology in children and adoles… (10.31549/2542-1174-2019-2-61-70) | Abstract References ORCID License | 60.21 | 3 |
| 7 | Frequency and features of non-alcoholic fatty liver disease/… (10.31549/2542-1174-2019-3-63-73) | Abstract References ORCID License | 60.21 | 3 |
| 8 | Community-acquired pneumonia: epidemiology, etiology and cli… (10.31549/2542-1174-2019-4-20-29) | Abstract References ORCID License | 60.21 | 3 |
| 9 | Features of the immune status of often and long-term sick ch… (10.31549/2542-1174-2019-4-30-40) | Abstract References ORCID License | 60.21 | 3 |
| 10 | A rationale for application of immobilized subtilisines for… (10.31549/2542-1174-2020-1-76-88) | Abstract References ORCID License | 60.21 | 3 |
| 11 | Lymphopenia as a determinant factor of sepsis severity, as… (10.31549/2542-1174-2020-3-108-125) | Abstract References ORCID License | 60.21 | 3 |
| 12 | The role of connective tissue dysplasias in pathology of var… (10.31549/2542-1174-2020-3-126-135) | Abstract References ORCID License | 60.21 | 3 |
| 13 | Possibilities of extracorporeal shock wave therapy in chroni… (10.31549/2542-1174-2018-4-13-25) | Abstract References ORCID License | 47.71 | 2 |
| 14 | Dynamics of abdominal pain syndrome in patients with choleli… (10.31549/2542-1174-2018-4-54-66) | Abstract References ORCID License | 47.71 | 2 |
| 15 | Tuberculosis in people with progressive HIV-infection (10.31549/2542-1174-2018-4-67-76) | Abstract References ORCID License | 47.71 | 2 |
| 16 | The state of ovarian reserve in patients with functional ova… (10.31549/2542-1174-2019-1-18-27) | Abstract References ORCID License | 47.71 | 2 |
| 17 | Peculiarities of judicial practice in dealing with cases inv… (10.31549/2542-1174-2019-2-18-28) | Abstract References ORCID License | 47.71 | 2 |
| 18 | Optimization of short-course treatment of patients with dors… (10.31549/2542-1174-2019-2-38-50) | Abstract References ORCID License | 47.71 | 2 |
| 19 | Modern epidemiological features of zooanthropophilic dermato… (10.31549/2542-1174-2019-2-71-78) | Abstract References ORCID License | 47.71 | 2 |
| 20 | Link between GATA3, FOXA1, ELF5 and clinicopathologic parame… (10.31549/2542-1174-2019-4-62-74) | Abstract References ORCID License | 47.71 | 2 |
| 21 | Features of modern diagnostics and pharmacotherapy of peripa… (10.31549/2542-1174-2021-4-134-148) | References ORCID License | 45.15 | 3 |
| 22 | Experimental evaluation of therapeutic properties of ointmen… (10.31549/2542-1174-2022-6-1-93-105) | References ORCID License | 45.15 | 3 |
| 23 | The comparison of methods for the quantification of the phar… (10.31549/2542-1174-2021-1-73-80) | References ORCID License | 35.78 | 2 |
| 24 | Morphological assessment of the mucous membranes of the blad… (10.31549/2542-1174-2021-2-56-64) | References ORCID License | 35.78 | 2 |
| 25 | The analgesic activity of new sulfur-containing di- and tetr… (10.31549/2542-1174-2021-3-45-55) | References ORCID License | 35.78 | 2 |
| 26 | Molecular subtypes of urothelial carcinomas of the bladder i… (10.31549/2542-1174-2021-3-82-104) | References ORCID License | 35.78 | 2 |
| 27 | Anti-inflammatory and analgesic activity of an inducible NO… (10.31549/2542-1174-2022-6-1-106-115) | References ORCID License | 35.78 | 2 |
| 28 | Development of hydrophilic gel based on sulfated arabinogala… (10.31549/2542-1174-2022-6-1-116-127) | References ORCID License | 35.78 | 2 |
| 29 | The role of probiotics in the correction of adverse events d… (10.31549/2542-1174-2022-6-4-15-24) | References ORCID License | 35.78 | 2 |
| 30 | Posttransplantation diabetes mellitus (10.31549/2542-1174-2018-4-26-33) | Abstract References ORCID License | 30.10 | 1 |
| 31 | Evaluation of the proliferative and antiproliferative proper… (10.31549/2542-1174-2019-1-28-35) | Abstract References ORCID License | 30.10 | 1 |
| 32 | Epidemiological aspects and prevention of tick-borne encepha… (10.31549/2542-1174-2019-1-36-48) | Abstract References ORCID License | 30.10 | 1 |
| 33 | Adaptive status of patients with bronchial asthma in the pre… (10.31549/2542-1174-2019-1-49-58) | Abstract References ORCID License | 30.10 | 1 |
| 34 | Stigma and discrimination against people living with HIV: th… (10.31549/2542-1174-2019-1-78-87) | Abstract References ORCID License | 30.10 | 1 |
| 35 | Modern aspects of acute gastroenteritis of viral etiology (10.31549/2542-1174-2019-2-106-117) | Abstract References ORCID License | 30.10 | 1 |
| 36 | Negative effect of cannabinoids on the course of paranoid sc… (10.31549/2542-1174-2019-2-79-84) | Abstract References ORCID License | 30.10 | 1 |
| 37 | Clinical assessment of the severity of chronic cystitis in w… (10.31549/2542-1174-2019-2-94-105) | Abstract References ORCID License | 30.10 | 1 |
| 38 | Quality of life in occupational chronic obstructive pulmonar… (10.31549/2542-1174-2019-3-24-32) | Abstract References ORCID License | 30.10 | 1 |
| 39 | Pharmacokinetics of an antiplatelet drug of indolinone serie… (10.31549/2542-1174-2019-3-44-51) | Abstract References ORCID License | 30.10 | 1 |
| 40 | The condition of the oral cavity in patients with MODY type… (10.31549/2542-1174-2019-3-74-83) | Abstract References ORCID License | 30.10 | 1 |
| 41 | Evaluation of protein changes of the myocardium in acute isc… (10.31549/2542-1174-2019-3-95-104) | Abstract References ORCID License | 30.10 | 1 |
| 42 | Possible risk factors and predictors of pneumonia developmen… (10.31549/2542-1174-2019-4-109-119) | Abstract References ORCID License | 30.10 | 1 |
| 43 | Assessment of nutritional status in arterial hypertension: t… (10.31549/2542-1174-2019-4-12-19) | Abstract References ORCID License | 30.10 | 1 |
| 44 | Quality system effectiveness in a pharmacy organization (10.31549/2542-1174-2019-4-54-61) | Abstract References ORCID License | 30.10 | 1 |
| 45 | Nutritional status and methods of its evaluation in patients… (10.31549/2542-1174-2020-1-116-127) | Abstract References ORCID License | 30.10 | 1 |
| 46 | The effectiveness of enzyme therapy in the comprehensive tre… (10.31549/2542-1174-2020-1-17-30) | Abstract References ORCID License | 30.10 | 1 |
| 47 | Plant phenolic compounds in prevention of metabolic disturba… (10.31549/2542-1174-2020-1-44-54) | Abstract References ORCID License | 30.10 | 1 |
| 48 | On the need for introducing the pharmaceutical-technological… (10.31549/2542-1174-2020-2-20-29) | Abstract References ORCID License | 30.10 | 1 |
| 49 | Development of methods for isolating medicinal substances fr… (10.31549/2542-1174-2020-2-30-41) | Abstract References ORCID License | 30.10 | 1 |
| 50 | Prognostic value of serum immunoglobulin free light chains i… (10.31549/2542-1174-2020-2-4-19) | Abstract References ORCID License | 30.10 | 1 |